| Income Statement | 2025-09-30 | 2025-06-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total other non-operating loss | -8,450 | -5,929 | 885 | |
| Loss before provision for income taxes | -16,504 | -17,140 | -15,479 | |
| Income tax benefit | 0 | -131 | - | |
| Net loss | -16,504 | -17,009 | -15,479 | |
| Basic (in dollars per share) | -0.14 | -0.15 | -0.17 | |
| Basic (in shares) | 97,474,797 | 93,203,665 | 74,748,365 | |
| Diluted (in dollars per share) | -0.14 | -0.15 | -0.17 | |
| Diluted (in shares) | 97,474,797 | 93,203,665 | 74,748,365 | |
Oncology Institute, Inc. (TOI)
Oncology Institute, Inc. (TOI)